Historical Valuation
Scotts Miracle-Gro Co (SMG) is now in the Undervalued zone, suggesting that its current forward PE ratio of 13.77 is considered Undervalued compared with the five-year average of 24.22. The fair price of Scotts Miracle-Gro Co (SMG) is between 67.10 to 145.32 according to relative valuation methord. Compared to the current price of 61.77 USD , Scotts Miracle-Gro Co is Undervalued By 7.94%.
Relative Value
Fair Zone
67.10-145.32
Current Price：61.77
7.94%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Scotts Miracle-Gro Co (SMG) has a current Price-to-Book (P/B) ratio of -9.60. Compared to its 3-year average P/B ratio of -1.40 , the current P/B ratio is approximately 585.02% higher. Relative to its 5-year average P/B ratio of 3.97, the current P/B ratio is about -341.64% higher. Scotts Miracle-Gro Co (SMG) has a Forward Free Cash Flow (FCF) yield of approximately 7.95%. Compared to its 3-year average FCF yield of 13.60%, the current FCF yield is approximately -41.60% lower. Relative to its 5-year average FCF yield of 7.35% , the current FCF yield is about 8.16% lower.
P/B
Median3y
-1.40
Median5y
3.97
FCF Yield
Median3y
13.60
Median5y
7.35
Competitors Valuation Multiple
AI Analysis for SMG
The average P/S ratio for SMG competitors is 0.94, providing a benchmark for relative valuation. Scotts Miracle-Gro Co Corp (SMG.N) exhibits a P/S ratio of 1.00, which is 6.96% above the industry average. Given its robust revenue growth of -6.61%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for SMG
1Y
3Y
5Y
Market capitalization of SMG increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of SMG in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is SMG currently overvalued or undervalued?
Scotts Miracle-Gro Co (SMG) is now in the Undervalued zone, suggesting that its current forward PE ratio of 13.77 is considered Undervalued compared with the five-year average of 24.22. The fair price of Scotts Miracle-Gro Co (SMG) is between 67.10 to 145.32 according to relative valuation methord. Compared to the current price of 61.77 USD , Scotts Miracle-Gro Co is Undervalued By 7.94% .
What is Scotts Miracle-Gro Co (SMG) fair value?
SMG's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Scotts Miracle-Gro Co (SMG) is between 67.10 to 145.32 according to relative valuation methord.
How does SMG's valuation metrics compare to the industry average?
The average P/S ratio for SMG's competitors is 0.94, providing a benchmark for relative valuation. Scotts Miracle-Gro Co Corp (SMG) exhibits a P/S ratio of 1.00, which is 6.96% above the industry average. Given its robust revenue growth of -6.61%, this premium appears unsustainable.
What is the current P/B ratio for Scotts Miracle-Gro Co (SMG) as of Jan 10 2026?
As of Jan 10 2026, Scotts Miracle-Gro Co (SMG) has a P/B ratio of -9.60. This indicates that the market values SMG at -9.60 times its book value.
What is the current FCF Yield for Scotts Miracle-Gro Co (SMG) as of Jan 10 2026?
As of Jan 10 2026, Scotts Miracle-Gro Co (SMG) has a FCF Yield of 7.95%. This means that for every dollar of Scotts Miracle-Gro Co’s market capitalization, the company generates 7.95 cents in free cash flow.
What is the current Forward P/E ratio for Scotts Miracle-Gro Co (SMG) as of Jan 10 2026?
As of Jan 10 2026, Scotts Miracle-Gro Co (SMG) has a Forward P/E ratio of 13.77. This means the market is willing to pay $13.77 for every dollar of Scotts Miracle-Gro Co’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Scotts Miracle-Gro Co (SMG) as of Jan 10 2026?
As of Jan 10 2026, Scotts Miracle-Gro Co (SMG) has a Forward P/S ratio of 1.00. This means the market is valuing SMG at $1.00 for every dollar of expected revenue over the next 12 months.